Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis

Experimental Cell Research

Volumn 252, Issue 2, 1999, Pages 464-470

  Liu, Yong Yu ^a   Han, Tie Yan ^a   Giuliano, Armando E ^a   Ichikawa, Shinichi ^b   Hirabayashi, Yoshio ^b   Cabot, Myles C ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Breast cancer; Ceramide; Drug resistance; Glycosylation; Tumor necrosis factor

Indexed keywords

CERAMIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA DEGRADATION; DNA SYNTHESIS; GENE EXPRESSION; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033231485     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4649     Document Type: Article

References (33)

1. Aggarwal B. B., Natarajan K. Tumor necrosis factors: Developments during the last decade. Eur. Cytokine Netw. 7:1996;93-124.
2. Fiers W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285:1991;199-212.
3. Larrick J. W., Wright S. C. Cytotoxic mechanism of tumor necrosis factor-α FASEB J. 4:1990;3215-3223.
4. Vandenabeele P., Declercq W., Beyaert R., Fiers T. Two tumor necrosis factor receptors: Structure and function. Trends Cell Biol. 5:1995;392-399.
5. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
6. Hannun Y. A. Function of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855-1859.
7. Nicholson D. W., Thormberry N. A. Caspase: Killer proteases. Trends Biochem. Sci. 22:1997;299-306.
8. Pena L. A., Fuks Z., Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathways. Biochem. Pharmacol. 53:1997;615-621.
9. Wiegmann K., Schutze S., Machchleidt T., Witte D., Kronke M. Functional dichotomy of neutral and acidic sphingomyelinase in tumor necrosis facotr signaling. Cell. 78:1994;1005-1015.
10. Cai Z., Bettaieb A., Mahdani N. E., Legres L. G., Stancou R., Masliah J., Chouaib S. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem. 272:1997;6918-6926.
11. Burow M. E., Weldon C. B., Tang Y., Navar G. L., Krajewski S., Reed J. C., Hammond T. G., Clejan S., Beckman B. S. Differences in susceptibility to tumor necrosis factor-α induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 58:1998;4940-4946.
12. Yoshimura S., Banno Y., Nakashima S., Takenaka K., Sakai H., Nishimura Y., Sakai N., Shimizu S., Eguchi Y., Tsujimoto Y., Nozawa Y. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death: Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J. Biol. Chem. 273:1998;6921-6927.
13. Monney L., Olivier R., Otter I., Jansen B., Poirier G. G., Borner C. Role of an acidic compartment in tumor-necrosis-factor-alpha-induced production of ceramide, activation of caspase-3 and apoptosis. Eur. J. Biochem. 251:1998;295-303.
14. Machleidt T., Geller P., Schwandner R., Scherer R., Kronke M. Caspase 7-induced cleavage of kinectin in apoptotic cells. FEBS Lett. 436:1998;51-54.
15. Zyad A., Benard J., Tursz T., Clarke R., Chouaib S. Resistance to TNF-α and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD and TNF gene expression. Cancer Res. 54:1994;825-831.
16. Bezombes C., Maestre N., Laurent G., Levade T., Bettaieb A., Jaffrezou J. P. Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC 833. FASEB J. 12:1998;101-109.
17. Basu S., Kaufeman B., Roseman S. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chicken brain. J. Biol. Chem. 243:1968;5802-5804.
18. Ichikawa S., Sakiyama H., Suzuki G., Hidari K. I. P., Hirabayashi Y. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl. Acad. Sci. USA. 93:1996;4638-4643.
19. Liu Y. Y., Han T. Y., Giuliano A. E., Cabot M. C. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274:1999;1140-1146.
20. Lavie Y., Cao H. T., Volner A., Lucci A., Han T. H., Geffen V., Giuliano A. E., Cabot M. C. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporine A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem. 272:1997;1682-1687.
21. Lavie Y., Cao H. T., Bursten S. L., Giuliano A. E., Cabot M. C. Accumulation of glucosylceramide in multidrug-resistant cancer cells. J. Biol. Chem. 271:1996;19530-19536.
22. Lavie Y., Zhang Z. C., Cao H. T., Han T. Y., Jones R. C., Liu Y. Y., Jarman M., Hardcastle I. R., Giuliano A. E., Cabot M. C. Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells. Int. J. Cancer. 77:1998;928-932.
23. Yang J. M., Chin K. V., Hait W. N. Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res. 56:1996;3490-3494.
24. Watanabe R., Wu K., Paul P., Marks D. L., Kobayashi T., Pittelknow M. R., Pagano R. E. Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J. Biol. Chem. 273:1998;9651-9655.
25. Chinnaiyan A. M., Tepper C. G., Seldin M. F., O'Rourke K., Kischkel F. C., Hellbardt S., Krammer P. H., Peter M. E., Dixit V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
26. Bourteele S., Hauber A., Doppler H., Horn-Muller J., Ropke C., Schwarzmann G., Pfizenmaier K., Muller G. Tumor necrosis factor induces ceramide oscillations and negatively controls sphingolipid synthases by caspases in apoptotic Kym-1 cells. J. Biol. Chem. 273:1998;31245-31251.
27. Ji L., Zhang G., Hirabayashi Y. Tumor necrosis factor alpha increases tyrosine phosphorylation of a 23-kDa nuclear protein in U937 cells through ceramide signaling pathway. Biochem. Biophys. Res. Commun. 215:1995;489-496.
28. Ji L., Zhang G., Uematsu S., Akahori Y., Hirabayashi Y. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358:1995;211-214.
29. Jeoung D. I., Tang B., Sonenberg M. Effects of tumor necrosis factor-α on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J. Biol. Chem. 270:1995;18367-18373.
30. Vieira K. B. L., Goldstein D. J., Villa L. L. Tumor necrosis factor α interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes. Cancer Res. 56:1996;2452-2457.
31. Jayadev S., Liu B., Bielawska A. E., Lee J. Y., Nazaire F., Pushkareva Y. M., Obeid L. M., Hannun Y. A. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270:1995;2047-2052.
32. Marsh N. L., Elias P. M., Holleran W. M. Glucosylceramides stimulate murine epidermal hyperproliferation. J. Clin. Invest. 95:1995;2903-2909.
33. Rani C. S. S., Abe A., Chang Y., Rosenzweig N., Saltiel A. R., Radin N. S., Shayman J. A. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. J. Biol. Chem. 270:1995;2859-2867.